← Leaderboards
Rajvir Dahiya
Northern California Institute Res &Educ
$21,076,281
Attributed
$21,076,281
Total exposure
17
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.9M · FY2005–21$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$21,076,281 · 14
VA$0 · 3
By mechanism
R01$18,682,923 · 12
U01$1,580,947 · 1
T32$812,411 · 1
I01$0 · 1
IK6$0 · 1
IP1$0 · 1
Top collaborators
- Yun-Fai Chris Lau4 shared
- Yuichiro Tanaka4 shared
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseGenesUntranslated RegionsMolecularTumor Suppressor GenesPublishingLiteraturePathway InteractionsMalignant NeoplasmsResearch StudyGene ExpressionIn VitroDna MethylationMethylationTumor ProgressionApoptosisProstateHistone AcetylationMicrornasCpg IslandsEpigenetic ProcessGrowthMediatingGene Targeting
Grant awards (82)
BLR&D Research Career Scientist Award Application$0
IK6 · FY2021 · VA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2020 · VA · contact PI
Regulation of c-Myc/HIF pathway in the management of kidney cancer$0
I01 · FY2020 · VA · contact PI
Molecular biomarkers for kidney cancer prognosis using non-coding RNAs$340,153
R01 · FY2019 · CA · contact PI
Genetic factors for race related prostate cancer.$308,555
U01 · FY2019 · CA · contact PI
Regulation of c-Myc/HIF pathway in the management of kidney cancer$0
I01 · FY2019 · VA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2019 · VA · contact PI
Molecular biomarkers for kidney cancer prognosis using non-coding RNAs$350,674
R01 · FY2018 · CA · contact PI
Genetic factors for race related prostate cancer.$318,098
U01 · FY2018 · CA · contact PI
Regulation of c-Myc/HIF pathway in the management of kidney cancer$0
I01 · FY2018 · VA · contact PI
Molecular biomarkers for kidney cancer prognosis using non-coding RNAs$350,674
R01 · FY2017 · CA · contact PI
Genetic factors for race related prostate cancer.$318,098
U01 · FY2017 · CA · contact PI
Regulation of c-Myc/HIF pathway in the management of kidney cancer$0
I01 · FY2017 · VA · contact PI
Molecular biomarkers for kidney cancer prognosis using non-coding RNAs$350,674
R01 · FY2016 · CA · contact PI
Genetic factors for race related prostate cancer.$318,098
U01 · FY2016 · CA · contact PI
Role of genetic biomarkers in clinical assessment of prostate cancer$0
IP1 · FY2016 · VA · contact PI
Chemo-dietary prevention, miRNAs, epigenetic and prostate cancer$453,482
R01 · FY2015 · CA · contact PI
Genetic factors for race related prostate cancer.$318,098
U01 · FY2015 · CA · contact PI
Role of genetic biomarkers in clinical assessment of prostate cancer$0
IP1 · FY2015 · VA · contact PI
Genistein, microRNAs and kidney cancer$0
I01 · FY2015 · VA · contact PI
MicroRNAs in the Progression and Metastisis of Prostate Cancer$509,008
R01 · FY2014 · CA · contact PI
Chemo-dietary prevention, miRNAs, epigenetic and prostate cancer$441,743
R01 · FY2014 · CA · contact PI
Role of genetic biomarkers in clinical assessment of prostate cancer$0
IP1 · FY2014 · VA · contact PI
Genistein, microRNAs and kidney cancer$0
I01 · FY2014 · VA · contact PI
MicroRNAs in the Progression and Metastisis of Prostate Cancer$495,564
R01 · FY2013 · CA · contact PI
Chemo-dietary prevention, miRNAs, epigenetic and prostate cancer$429,926
R01 · FY2013 · CA · contact PI
Genistein, microRNAs and kidney cancer$0
I01 · FY2013 · VA · contact PI
Role of genetic biomarkers in clinical assessment of prostate cancer$0
IP1 · FY2013 · VA · contact PI
Wnt antagonist genes in kidney tumor progression and metastasis$601,339
R01 · FY2012 · CA · contact PI
MicroRNAs in the Progression and Metastisis of Prostate Cancer$529,714
R01 · FY2012 · CA · contact PI
Chemo-dietary prevention, miRNAs, epigenetic and prostate cancer$459,367
R01 · FY2012 · CA · contact PI
Genistein, microRNAs and kidney cancer$0
I01 · FY2012 · VA · contact PI
Wnt antagonist genes in kidney tumor progression and metastasis$603,974
R01 · FY2011 · CA · contact PI
MicroRNAs in the Progression and Metastisis of Prostate Cancer$531,947
R01 · FY2011 · CA · contact PI
Chemo-dietary prevention, miRNAs, epigenetic and prostate cancer$461,404
R01 · FY2011 · CA · contact PI
Urological Research Training Program$1
T32 · FY2011 · DK · contact PI
Wnt antagonist genes in kidney tumor progression and metastasis$625,454
R01 · FY2010 · CA · contact PI
MicroRNAs in the Progression and Metastisis of Prostate Cancer$549,290
R01 · FY2010 · CA · contact PI
Diabetes Erectile dysfunction and apoptosis of cavernous tissues$304,362
R01 · FY2010 · DK · contact PI
Genistein and Prostate Cancer$271,628
R01 · FY2010 · CA · contact PI
Urological Research Training Program$111,812
T32 · FY2010 · DK · contact PI
Wnt antagonist genes in kidney tumor progression and metastasis$616,010
R01 · FY2009 · CA · contact PI
Diabetes Erectile dysfunction and apoptosis of cavernous tissues$307,437
R01 · FY2009 · DK · contact PI
Cytochrome-P-450 genes in pathobiology of endometrial cancer$283,708
R01 · FY2009 · CA · contact PI
Genistein and Prostate Cancer$271,628
R01 · FY2009 · CA · contact PI
Urological Research Training Program$110,982
T32 · FY2009 · DK · contact PI
Wnt antagonist genes in kidney tumor progression and metastasis$600,893
R01 · FY2008 · CA · contact PI
Diabetes Erectile dysfunction and apoptosis of cavernous tissues$307,437
R01 · FY2008 · DK · contact PI
Cytochrome-P-450 genes in pathobiology of endometrial cancer$283,708
R01 · FY2008 · CA · contact PI
Genistein and Prostate Cancer$271,628
R01 · FY2008 · CA · contact PI
Urological Research Training Program$120,619
T32 · FY2008 · DK · contact PI
Diabetes Erectile dysfunction and apoptosis of cavernous tissues$313,711
R01 · FY2007 · DK · contact PI
Cytochrome-P-450 genes in pathobiology of endometrial cancer$283,708
R01 · FY2007 · CA · contact PI
CYP1A1 and CYP1B1 genes in race-related Prostate Cancer$278,480
R01 · FY2007 · CA · contact PI
Genistein and Prostate Cancer$271,628
R01 · FY2007 · CA · contact PI
Urological Research Training Program$93,414
T32 · FY2007 · DK · contact PI
Diabetes Erectile dysfunction and apoptosis of cavernous tissues$322,721
R01 · FY2006 · DK · contact PI
DNA methylation in aging, race and prostate cancer$322,245
R01 · FY2006 · AG · contact PI
Cytochrome-P-450 genes in pathobiology of endometrial cancer$292,181
R01 · FY2006 · CA · contact PI
CYP1A1 and CYP1B1 genes in race-related Prostate Cancer$286,798
R01 · FY2006 · CA · contact PI
Genistein and Prostate Cancer$279,119
R01 · FY2006 · CA · contact PI
DNA methylation in aging, race and prostate cancer$330,000
R01 · FY2005 · AG
Cytochrome-P-450 genes in pathobiology of endometrial cancer$299,213
R01 · FY2005 · CA
CYP1A1 and CYP1B1 genes in race-related Prostate Cancer$293,700
R01 · FY2005 · CA
DNA methylation in aging, race and prostate cancer$330,000
R01 · FY2004 · AG
CYP1A1 and CYP1B1 genes in race-related Prostate Cancer$293,700
R01 · FY2004 · CA
UROLOGICAL RESEARCH TRAINING PROGRAM$83,826
T32 · FY2004 · DK
DNA methylation in aging, race and prostate cancer$303,000
R01 · FY2003 · AG
CYP1A1 and CYP1B1 genes in race-related Prostate Cancer$269,670
R01 · FY2003 · CA
UROLOGICAL RESEARCH TRAINING PROGRAM$26,523
T32 · FY2003 · DK
DNA methylation in aging, race and prostate cancer$303,000
R01 · FY2002 · AG
AGING AND PROSTATE GROWTH$265,161
R01 · FY2002 · AG
DIABETES AND ERECTILE FUNCTION$239,686
R01 · FY2002 · DK
UROLOGICAL RESEARCH TRAINING PROGRAM$105,955
T32 · FY2002 · DK
ESTROGEN AND PROSTATIC GROWTH$271,123
R01 · FY2001 · DK
AGING AND PROSTATE GROWTH$258,117
R01 · FY2001 · AG
DIABETES AND ERECTILE FUNCTION$232,705
R01 · FY2001 · DK
UROLOGICAL RESEARCH TRAINING PROGRAM$108,228
T32 · FY2001 · DK
ESTROGEN AND PROSTATIC GROWTH$263,226
R01 · FY2000 · DK
AGING AND PROSTATE GROWTH$251,278
R01 · FY2000 · AG
DIABETES AND ERECTILE FUNCTION$225,927
R01 · FY2000 · DK
UROLOGICAL RESEARCH TRAINING PROGRAM$51,051
T32 · FY2000 · DK